FACULTY
Virgil Van Dusen, RPh, JD
Bernhardt Professor of Pharmacy
Southwestern Oklahoma State University
College of Pharmacy
Weatherford, OK

FINANCIAL DISCLOSURE
Virgil Van Dusen has no real or apparent conflicts of interest in relation to this program.

ACCREDITATION STATEMENTS
Pharmacy
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Program No.: 430-000-07-022-H03-P; 430-000-07-022-H03-T
Credits: 2.0 hours (0.20 ceu)

Media: Monograph

Fee Information:
There is no fee for this educational program.

Estimated time to complete activity:
Estimated time to complete this program and posttest is 90 to 120 minutes.

Exam processing inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696

Direct educational content inquiries to:
CE Director (800) 331-9396

PROCEDURES
Please complete the posttest questions and program evaluation online at: www.powerpak.com (a username and password are required to access your account). Upon passing the exam with a score of 70% or better, you can print out your statement of credit immediately. You can also view your test history at any time and print out duplicate statements from the Web site.

TARGET  AUDIENCE
This educational program is targeted to pharmacists and pharmacy technicians.

GOAL
To provide an overview of current health care initiatives to encourage substitution with generic drugs, the variations in state laws to recommend and/or mandate substitution, and the economic impact associated with generic substitution, as well as to provide guidelines to appropriately adhere to substitution regulations.

EDUCATIONAL OBJECTIVES
After completing this program, participants will be able to:

1. Provide an overview of current health care initiatives to encourage substitution with generic drugs;*
2. Discuss the variations in state laws to recommend and/or mandate generic substitution;*
3. Describe the economic impact associated with generic substitution, especially as it relates to Medicare Part D;* and
4. List guidelines for pharmacists to appropriately adhere to generic drug substitution.

*Also applies to pharmacy technicians.

Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of, and should not be attributed to, Postgraduate Healthcare Education, LLC and Mylan Pharmaceuticals Inc. As the sponsor of this educational activity, Mylan Pharmaceuticals Inc. does not control the author or the contents of this presentation. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The author and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.